Document is current

Any future updates will be listed below

Impact of prophylactic skin toxicity management on treatment continuity and clinical outcomes in EGFR-mutant non-small cell lung cancer treated with osimertinib: a 7-year real-world retrospective cohort study

Crossref DOI link: https://doi.org/10.1007/s00520-026-10896-4

Published Online: 2026-06-13

Published Print: 2026-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark